Therapeutic approach to patients with rheumatoid arthritis and chronic HBV/HCV infection
| Autor: | Daniela Opris, Sinziana Daia-Iliescu, Bogdan Toia, Ruxandra Ionescu |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
medicine.medical_specialty
Pathology business.industry virus diseases Hydroxychloroquine medicine.disease Infliximab digestive system diseases Etanercept Liver disease Therapeutic approach Medical microbiology Infectious Diseases Rheumatoid arthritis Internal medicine Concomitant Poster Presentation Medicine business medicine.drug |
| Zdroj: | BMC Infectious Diseases |
| ISSN: | 1471-2334 |
| DOI: | 10.1186/1471-2334-14-s7-p73 |
| Popis: | Background Treating chronic HCV/HBV-infected patients with concomitant rheumatoid arthritis (RA) may be a challenge to the clinician. The liver disease limits to some degree the treatment for the rheumatic disease as the drugs used are hepatotoxic or at risk of infection reactivation. The aim of the study is to evaluate the particularities and the safety of RA treatment in patients with both conditions and to investigate the prevalence of HBV/ HCV-infections in RA patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|